With employer-provided health benefits costs expected to increase globally in 2020, mental and behavioural conditions are predicted to become more common over the next five years, according to a new survey by Willis Towers Watson. The annual survey of global medical insurers found health-care costs are expected to rise at a similar rate as previous […]
While nearly two-thirds (63 per cent) of Canadian plan sponsors believe their benefits plans meet current workforce diversity needs, 87 per cent noted employee expectations for benefits and the workplace have changed, according to a survey from Aon. Today’s employees expect more flexible working hours (84 per cent), support to achieve work-life balance (79 per […]
After the Arthritis Society’s extensive advocacy for medical cannabis research, it seemed only natural for the organization to cover the drug under its employee benefits plan. In 2017, as it prepared to introduce the coverage, it brought together an expert panel, including doctors with extensive experience prescribing medical cannabis and expert pharmacists and advisors from […]
The Canadian Life and Health Insurance Association has published a guide to help health-care providers and patients understand private health insurance. The guide, released during financial literacy month, was produced with the Extended Healthcare Professionals Coalition, a group that represents medical professionals, including psychologists, physiotherapists, audiologists, occupational therapists, chiropractors and pharmacists, among others. It’s geared toward […]
On Oct. 24, the 2019 Calgary Drug Trends Summit featured presentations to educate plan sponsors and advisors about specific disease states and their challenges, new drug treatment categories and key drug trends facing benefits plans. Here’s what you missed! New drug therapies for common conditions could impact private plan sustainability While medical advancements and drug […]
While medical advancements and drug therapy innovations have been life-changing for patients and plan members, they also come with increasing costs, said Victoria Shaw, drug benefits manager at Alberta Blue Cross, speaking at Benefits Canada’s 2019 Calgary Drug Trends Summit on Oct. 24. Between 2011 to 2017, the number of high-cost drugs doubled. From 2016 to 2017, in […]
Only eight per cent of Canadian women who are eligible for a vaccine that covers nine strains of the human papillomavirus are actually receiving it. While one barrier is a lack of knowledge among health-care professionals and patients alike, another is the lack of coverage in group benefits plans, said Dr. Angel Chu, an infectious diseases physician at Foothills Medical Centre, […]
When it comes to switching from a biologic to a biosimilar drug, patient choice and engagement is extremely important, according to Durhane Wong-Rieger, president and chief executive officer of the Canadian Organization for Rare Disorders. “While a patient’s on a drug, they need to be continuously monitoring,” she said during a session at Benefits Canada’s 2019 Calgary Drug […]
Alongside Fluor Canada’s recent move to a flexible benefits plan, it also introduced a managed drug formulary, which includes generic substitution, prior authorization, lifetime maximums and an annual out-of-pocket maximum. While the organization was hesitant to make the change, it knew it was necessary to help control drug costs, said Michelle Ginter, senior human resources […]
When it came to asking his employer to add continuous glucose monitoring to its benefits package, John Whitehead, a level-two food server at Niagara Casinos, went all in. He’s had type 1 diabetes for years, and lived through many technological developments to help manage his condition. While he says blood glucose monitoring represented a major improvement, it […]